BSEAmal LtdMediumNeutral
Announced Fri, 11 Jul · 16:26 IST

Appointment in Dr Mahabaleshwar Ganpat Palekar as an additional Independent Director effective August 01, 2025.

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Amal Ltd has appointed Dr Mahabaleshwar Ganpat Palekar as an additional Independent Director on its Board, effective August 1, 2025, for a five-year term subject to shareholder approval. Dr Palekar, aged 67, brings over three decades of experience in management and strategic planning. He has previously served as President – Pharmaceuticals Business at Atul Ltd and Managing Director of Atul Bioscience Ltd, and was Regional Business Director – Asia Pacific and Middle East at Rhodia India. He currently sits on the boards of Camlin Fine Sciences Ltd and its group companies. The appointment was made on the recommendation of the Nomination and Remuneration Committee.

Likely market impact

This is a routine governance update with no direct impact on shareholders or stock price. The addition of an experienced independent director may strengthen board oversight, though the appointment remains subject to shareholder approval.